gaap:OperatingSegmentsMember
mrk:AlliancerevenueLynparzaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:AlliancerevenueLynparzaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:AlliancerevenueLynparzaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:LenvimaMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:LenvimaMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:LenvimaMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:LenvimaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:LenvimaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:LenvimaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:WeliregMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:WeliregMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:WeliregMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:WeliregMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:WeliregMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:WeliregMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueReblozylMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueReblozylMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueReblozylMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueReblozylMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueReblozylMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueReblozylMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:GardasilGardasil9Member
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:GardasilGardasil9Member